TMDX - TransMedics Group, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

TransMedics Group, Inc.

200 Minuteman Road
Suite 302
Andover, MA 01810
United States

IndustryMedical Devices
Full Time Employees94

Key Executives

NameTitlePayExercisedYear Born
Dr. Waleed H. HassaneinFounder, CEO, Pres & Director524kN/A1968
Mr. Stephen GordonCFO. Treasurer & Sec.371.25kN/A1968
Dr. Tamer I. KhayalChief Commercial Officer415.8kN/A1969
Mr. John F. CareyVP of OperationsN/AN/A1964
Mr. Ike OkonkwoVP of Fin. & AccountingN/AN/A1971
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Transmedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG, a portable perfusion, ventilation, and monitoring system that maintains the organ at a near-physiologic state allowing physicians to assess and improve the condition of lungs between the donor and recipient sites; OCS Heart, a portable, warm perfusion, and monitoring system designed to keep a donor heart at a human-like, metabolically active state; and OCS Liver, a system that is evaluated in clinical trials for utilized and unutilized donor livers. The company offers its products in the United States and internationally. Transmedics Group, Inc. was founded in 1998 and is headquartered in Andover, Massachusetts.

Corporate Governance

TransMedics Group, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.